Global Evidence for the Use of Calcium for PE/E Prevention Jeffrey Michael Smith, MD, MPH Jhpiego / Johns Hopkins University Maternal Health Team Leader.

Slides:



Advertisements
Similar presentations
 may be efective in preventing SGA birth in women at high risk of preeclampsia although the effect size is small. (c)
Advertisements

Journal Club October 2012 Supervised by Prof.Abdulrahim Rouzi Presented by Dr.Ayman Bukhari.
The ACOG Task force on hypertension in pregnancy
The Research Question Alka M. Kanaya, MD Associate Professor of Medicine, Epidemiology & Biostatistics UCSF October 3, 2011.
Medical Statistics Joan Morris Professor of Medical Statistics Goldsmiths Lecture 2014.
IMPACT OF PREECLAMPSIA ON BIRTH OUTCOMES Xu Xiong, MD, DrPH Department of Obstetrics and Gynecology Université de Montréal, Quebec, Canada.
Update on Anti-platelets Gabriel A. Vidal, MD Vascular Neurology Ochsner Medical Center October 14 th, 2009.
THYROID DISEASE IN PREGNANCY: TREATING TWO PATIENTS Susan J. Mandel, MD MPH Perelman School of Medicine, University of Pennsylvania.
Dr. Y. Shah MD, Associate Dean of Global Health, DMU Lindsay Zylstra, Central College.
Leadership. Knowledge. Community. Canadian Cardiovascular Society Antiplatelet Guidelines USE OF ANTIPLATELET THERAPY IN WOMEN WHO ARE PREGNANT OR BREASTFEEDING.
1 Dr Kunal Bagchi Regional Adviser – Nutrition & Food Safety WHO South-East Asia Regional Office Kathmandu, Nepal November 2011.
- Salt Reduction - Trojan Horse of Public Health Policy Appears attractive on surface, but conceals great risk to consumers! Morton Satin Vice President,
Prevention of preeclampsia Jim Roberts. Introduction The NICHD/NHLBI will soon begin a very large (9 to 12,000 women) and very expensive study of antioxidant.
UOG Journal Club: September 2012 Perinatal outcome in women treated with progesterone for the prevention of preterm birth: a meta-analysis Sotiriadis A,
Improved Labor Care to Reduce Neonatal Asphyxia Jeffrey M. Smith Maternal Health Team Leader Interventions for Impact in Essential Obstetric and Newborn.
Progesterone Therapy for Preterm Labor Perinatal Conference April 14, 2006.
We can prevent mortality from eclampsia Harshad Sanghvi Vice President & Medical Director, Jhpiego Monday 8 March, 2010, Bangkok, Thailand.
Effectiveness of interactive web-based lifestyle program on prevention of cardiovascular diseases risk factors in patient with metabolic syndrome: a randomized.
Is Unintended Pregnancy Associated with Increased Blood Pressure during Pregnancy? Author Author Author Date PH 251A.
Nutrition and Micronutrients in Pregnancy Advances in Maternal and Neonatal Health.
Vitamins - what is the evidence? Rohan Subasinghe.
Maternal Nutrition during Pregnancy and Lactation BY PROFESSOR JIB ADINMA DEPARTMENT OF OBS/GYN NNAMDI AZIKIWE UNIVERSITY TEACHING HOSPITAL NNEWI, NIGERIA.
Dr.Zhila Abedi Asl MD.Fellowship of lnfertility Tehran medical university.
Anticoagulant therapy in RPL Dr. Z. Heidar Assistant professor SBMU.
Headache, Blurred Vision, Convulsions, Loss of Consciousness or Elevated Blood Pressure Advances in Maternal and Neonatal Health.
 To educate pregnant women on the importance of prenatal care and educate them on the complications that pertain to human pregnancy.  To be knowledgeable.
An example of using data from multiple longitudinal studies to address a scientific hypothesis: Maternal iron in pregnancy and offspring’s cardiovascular.
Women's Health Study: Low-Dose Aspirin in Primary Prevention Presented at American College of Cardiology Scientific Sessions 2005 Presented by Dr. Dr.
Asthma and Pregnancy Michael Schatz, MD, MS Chief, Department of Allergy Kaiser-Permanente Medical Center San Diego, CA.
Child Health Research Project Research Results and Policy Formulation on Nutrition and Micronutrients.
Child deaths: Causes and epidemiological dimensions Robert E. Black, M.D., M.P.H. Johns Hopkins Bloomberg School of Public Health.
Calcium supplementation for preventing pre-eclampsia/eclampsia Justus Hofmeyr, for the Calcium and Pre-eclampsia (CAP) Study Group* *Fernando Althabe,
Medical Management of obesity Perinatal ANGELS Conference Feb 17, 2005 Philip A. Kern.
| Africa Regional Meeting on Interventions for Impact in Essential Maternal and Newborn Care, Addis Ababa, Feb 21, 2011 Timing of delivery and induction.
TEMPLATE DESIGN © Diet Plus Insulin Compared to Diet Alone In The Treatment of GDM Mothers in HUSM, Kelantan. Wan Faizah.
05_XXX_MM1 MATERNAL AND PERINATAL RESEARCH José Villar, Mariana Widmer, Mario Merialdi, Archana Shah for the WHO Maternal and Perinatal Research Network.
Healthy Women, Healthy Babies Jeffrey Levi, PhD Executive Director Trust for America’s Health.
Vaginal Birth After Cesarean: Is it Still an Option
Should developing countries continue to use older drugs for essential hypertension? A prescription survey in South Africa suggested that prescribers were.
HOPE: Heart Outcomes Prevention Evaluation study Purpose To evaluate whether the long-acting ACE inhibitor ramipril and/or vitamin E reduce the incidence.
Naotsugu Oyama, MD, PhD, MBA A Trial of PLATelet inhibition and Patient Outcomes.
What is the Minimum Effective Dose of Folic Acid for Preventing NTDs? James L. Mills, M.D., M.S. Caroline Signore, M.D. NICHD.
Greg Gaines PA-S A RANDOMIZED TRIAL OF GLUTAMINE AND ANTIOXIDANTS IN CRITICALLY ILL PATIENTS.
SARAH PIXTON AUGUST 2013 ORANGE BASE HOSPITAL Low Dose Aspirin In Pregnancy.
Aspirin for Pre- eclampsia? Max Brinsmead MB BS PhD July 2015.
Can Folic Acid Prevent AMD? Rick Trevino, OD Evansville VA Clinic
Preeclampsia Prevention Krishna Khanal, MD RIII Cedar Rapids Medical Education Foundation.
The evidence for going to scale with Calcium supplementation Harshad Sanghvi Vice-President & Medical Director, Jhpiego Senior Advisor, Accelovate/USAID,
Authors: Dr. Majid Valizadeh Dr. Zahra Piri Dr. Kourosh Kamali Dr. Farnaz Mohammadian Dr. Hamidreza Amirmioghadami Presenter: Piri Z. MD.
UOG Journal Club: May 2016 Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis S. Roberge, S. Demers, K.H.
Hypnosis Antenatal Training for Childbirth (HATCh): a randomised controlled trial A.M Cyna, C.A Crowther, J.S Robinson, M.I Andrew, G Antoniou, P Baghurst.
Stillbirth in twins, exploring the optimal gestational age for delivery: a retrospective cohort study S Wood, S Tang, S Ross, R Sauve.
UOG Journal Club: March 2017
Objective: To assess the prevalence of anemia in a sample of Jordanian pregnant women and to find out whether packed cell volume (PCV) affected by the.
UOG Journal Club: October 2017
UOG Journal Club: May 2016 Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis S. Roberge, S. Demers, K.H.
25 – 26 March 2013 University of Oxford Intubation or CPAP ?
On behalf of The MTN-020/ASPIRE Study Team
James M. Roberts, M.D., Leslie Myatt, Ph.D.,et al.
Twin Pregnancy and Iron Deficiency Anemia: What You Need to Know?
HOPE: Heart Outcomes Prevention Evaluation study
Tabassum Firoz MD MSc FRCPC University of British Columbia
a systematic review and meta-analysis
UOG Journal Club: March 2017
Intrauterine growth restriction: A new concept in antenatal management
Nurses' Health Study: Risk of hypertension associated with >1000 µg/day of folate vs
UOG Journal Club: July 2012 Maternal hemodynamics at 11–13 weeks’ gestation and risk of pre-eclampsia A. Khalil, R. Akolekar, A. Syngelaki, M. Elkhouli.
MARFAN SARTAN Trial design: Marfan patients were randomized to losartan (n = 153) vs. placebo (n = 150). The dose of losartan was 50 mg for those
Section 6: Update on lipid treatment guidelines
Omega-3 fatty acid supplements during pregnancy
Presentation transcript:

Global Evidence for the Use of Calcium for PE/E Prevention Jeffrey Michael Smith, MD, MPH Jhpiego / Johns Hopkins University Maternal Health Team Leader MCHIP Kathmandu, 9 December 2013

2 Pre-eclampsia Quick reminder:  Blood pressure ≥ 140 / 90  Proteinuria  In a pregnant woman ≥ 20 weeks or greater, with no pre-pregnancy history of pre-eclampsia

Dietary modification program in Sydney RHJ Hamlin Lancet 1952

Experience in Ethiopia Hamlin RHJ. Prevention of pre-eclampsia. Lancet 1962;1:

Pre-eclampsia and dietary calcium  Low incidence of pre-eclampsia noted in Guatemala (Belizan 1980)  Postulated due to high calcium diets Belizan JM, Villar J. The relationship between calcium intake and edema, proteinuria, and hypertension-gestosis: an hypothesis. American Journal of Clinical Nutrition 1980;33:

Calcium supplementation among low calcium intake women: WHO randomized trial Villar J, Abdel-Aleem H, Merialdi M, Mathai M, Ali M, Zavaleta N, Purwar M, Hofmeyr GJ, thi Nhu Ngoc N, Campódonico L, Landoulsi S, Carroli G, Lindheimer M et al. Am J Obstet Gynecol 2006;194: ↓ Revised Systematic Review: Hofmeyr GJ, Lawrie TA, Atallah ÁN, Duley L. Cochrane Database of Syst Reviews 2010

Calcium vs Placebo: Pre-eclampsia

Calcium vs Placebo: Proteinuria

Calcium vs Placebo: Eclampsia

Calcium vs Placebo: Maternal Death

Calcium vs Placebo: Maternal death / severe morbidity

Calcium vs Placebo: Preterm birth

Calcium and pre-eclampsia  Epidemiological association of dietary calcium deficiency with pre-eclampsia / eclampsia  Calcium supplementation reduces:  Pre-eclampsia by 64% (but only 8% in WHO trial)  Severe morbidity by 20%  Preterm birth by 10% (borderline significance)  Increases HELLP syndrome

Hypothesis: Calcium supplementation in 2 nd half of pregnancy:  ↓ blood pressure (↓ vascular tone)  ↓ serious complications related to hypertension  No effect on ‘underlying pre-eclampsia process’  ↓ early deliveries in Ca group → more women went on to develop HELLP syndrome  To prevent underlying pre-eclampsia process may need adequate calcium from before pregnancy Hofmeyr G, Duley L, Atallah A.Hofmeyr G, Duley L, Atallah A. Dietary calcium supplementation for prevention of pre-eclampsia and related problems: a systematic review and commentary. BJOG. 2007; 114:

Based on this evidence:  World Health Organization recommends (2011) calcium supplementation with 1.5 to 2g calcium daily to pregnant women with low dietary calcium intake  BUT:  Large dose difficult to implement  May be unnecessarily large, or even harmful

Daily intake of calcium per capita in developing/developed countries (FAO, 1990) REGIONCALCIUM (mg) World472 Developed countries860 Developing countries346 Africa 363 Latin America499 Near East498 Far East352 Others402 About 500 mg

 Cochrane methodology  Primary inclusion criteria:  Calcium supplementation <1g without co-supplements  Secure allocation concealment (low risk of bias)  Double blinding with placebo  If the above criteria failed to produce adequate data, we planned to include:  quasi-randomized trials  trials without placebo control  trials of multiple supplements,  with appropriate caution in the interpretation

Cochrane review: Low dose calcium

Results  All trials used 500mg daily  Consistent 60% reduction in pre-eclampsia across all 9 trials (2234 women)  Significant reduction for all high quality trials; and all trials of calcium alone  An unexpected finding in one high quality trial of calcium plus antioxidants commencing at 8-12 weeks of pregnancy was a trend to reduced miscarriage (1/29 versus 8/31, RR 0.06, 95% CI 0.00 to 1.04).

Conclusions  Available evidence supports the probable effectiveness of low-dose calcium supplementation  Low quality of evidence requires further research  If the WHO recommendation of 1.5 to 2g calcium daily is not achievable, it is reasonable to use a lower dosage (eg 500mg daily)

The Calcium and Pre-eclampsia (CAP) study (WHO Study A65750)  Randomized trial: calcium 500mg daily vs placebo commencing before conception till 20 weeks  All women receive routine calcium in second half of pregnancy  Participants: women with previous pre-eclampsia who intend to conceive  If effective, next step will be food fortification  Analysis plan includes measuring effect on conception and miscarriage.

22 THANK YOU